| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927894 | American Heart Journal | 2012 | 14 Pages |
Abstract
Erythropoietin in patients with AMI seems to have no clinical benefit for heart function or reducing infarct size, cardiovascular events, and all-cause mortality. Erythropoietin may not be a choice for patients with AMI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dengfeng PhD, Ning M Med, Xiaolin M Med, Yinhu M Med, Xin M Med, Jin MD, Canzhan MD,